For Black Americans, the pandemic spike in fentanyl deaths was decades in the making
A new CDC report shows that more Black Americans died from fentanyl overdoses than from any other drug in 2021 and at far higher rates than whites or Hispanics.
A new CDC report shows that more Black Americans died from fentanyl overdoses than from any other drug in 2021 and at far higher rates than whites or Hispanics.
A new CDC report shows that more Black Americans died from fentanyl overdoses than from any other drug in 2021 and at far higher rates than whites or Hispanics.
A new CDC report shows that more Black Americans died from fentanyl overdoses than from any other drug in 2021 and at far higher rates than whites or Hispanics.
The CDC’s 2021 Youth Risk Behavior Survey offers a troubling window into high school students’ physical, emotional and mental health
The CDC’s 2021 Youth Risk Behavior Survey offers a troubling window into high school students’ physical, emotional and mental health
A new CDC report shows that more Black Americans died from fentanyl overdoses than from any other drug in 2021 and at far higher rates than whites or Hispanics.
The CDC’s 2021 Youth Risk Behavior Survey offers a troubling window into high school students’ physical, emotional and mental health
The CDC’s 2021 Youth Risk Behavior Survey offers a troubling window into high school students’ physical, emotional and mental health
The CDC’s 2021 Youth Risk Behavior Survey offers a troubling window into high school students’ physical, emotional and mental health
The CDC’s 2021 Youth Risk Behavior Survey offers a troubling window into high school students’ physical, emotional and mental health
The CDC’s 2021 Youth Risk Behavior Survey offers a troubling window into high school students’ physical, emotional and mental health
The CDC’s 2021 Youth Risk Behavior Survey offers a troubling window into high school students’ physical, emotional and mental health
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Scaling back on vaccine clinics and not updating staff vaccine requirements has slowed down booster rates at nursing homes, advocates say.
Only 15.3 percent of eligible Americans — or about 50 million people — have received the bivalent vaccine.
Only 15.3 percent of eligible Americans — or about 50 million people — have received the bivalent vaccine.
Only 15.3 percent of eligible Americans — or about 50 million people — have received the bivalent vaccine.
Only 15.3 percent of eligible Americans — or about 50 million people — have received the bivalent vaccine.
Only 15.3 percent of eligible Americans — or about 50 million people — have received the bivalent vaccine.
Only 15.3 percent of eligible Americans — or about 50 million people — have received the bivalent vaccine.